JP2021520484A - ラテラルフロー免疫アッセイストリップ装置 - Google Patents

ラテラルフロー免疫アッセイストリップ装置 Download PDF

Info

Publication number
JP2021520484A
JP2021520484A JP2020554068A JP2020554068A JP2021520484A JP 2021520484 A JP2021520484 A JP 2021520484A JP 2020554068 A JP2020554068 A JP 2020554068A JP 2020554068 A JP2020554068 A JP 2020554068A JP 2021520484 A JP2021520484 A JP 2021520484A
Authority
JP
Japan
Prior art keywords
sample
conjugate
pad
target peptide
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2020554068A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019192978A5 (https=
JP2021520484A5 (https=
Inventor
イェルク−エム．ホリッド
トーマス、ボグシュ
フランツィスカ、ベルナー
ハーディー、キーツマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JP2021520484A publication Critical patent/JP2021520484A/ja
Publication of JPWO2019192978A5 publication Critical patent/JPWO2019192978A5/ja
Publication of JP2021520484A5 publication Critical patent/JP2021520484A5/ja
Ceased legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Metal Rolling (AREA)
  • Peptides Or Proteins (AREA)
JP2020554068A 2018-04-03 2019-04-02 ラテラルフロー免疫アッセイストリップ装置 Ceased JP2021520484A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18165380.9 2018-04-03
EP18165380 2018-04-03
PCT/EP2019/058224 WO2019192978A1 (en) 2018-04-03 2019-04-02 Lateral flow immunoassay strip device

Publications (3)

Publication Number Publication Date
JP2021520484A true JP2021520484A (ja) 2021-08-19
JPWO2019192978A5 JPWO2019192978A5 (https=) 2022-03-31
JP2021520484A5 JP2021520484A5 (https=) 2022-03-31

Family

ID=61868418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020554068A Ceased JP2021520484A (ja) 2018-04-03 2019-04-02 ラテラルフロー免疫アッセイストリップ装置

Country Status (6)

Country Link
US (1) US12123873B2 (https=)
EP (1) EP3775896B1 (https=)
JP (1) JP2021520484A (https=)
CN (1) CN111868528B (https=)
ES (1) ES2953017T3 (https=)
WO (1) WO2019192978A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024075545A (ja) * 2022-11-23 2024-06-04 弗雷米徳生物医薬技術（天津）有限公司 子宮頸癌ｅ７タンパク質検出用抗体抗原検出キット及びその検出方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020232313A1 (en) * 2019-05-14 2020-11-19 Inscent, Inc. Lateral flow device for target analyte detection using chemosensory proteins
JP7540903B2 (ja) * 2020-06-19 2024-08-27 デンカ株式会社 流路とコロイド粒子を用いた被検物質検出方法
EP4260065A1 (en) * 2020-12-11 2023-10-18 Huvepharma Inc. Lateral flow assay for detection of monensin
CN117940772A (zh) 2021-05-18 2024-04-26 2Pi西格玛公司 使用对含有目标分析物的外泌体具有特异性的抗体的夹心免疫测定装置
CN114002443A (zh) * 2021-11-03 2022-02-01 厦门宝太生物科技股份有限公司 可滤血色素冻干球均相发光免疫检测试剂盒及其制备方法
CN120936877A (zh) * 2023-03-21 2025-11-11 新生命医药科技有限公司 用于前列腺癌筛查的基于侧流免疫测定的精胺快速检测
TW202528550A (zh) * 2023-11-09 2025-07-16 香港大學 用於非侵入性快速測試鼻咽癌中存在之ｄｎａ、ｒｎａ及蛋白質標記之組合物及方法

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06504846A (ja) * 1991-01-11 1994-06-02 クイデル　コーポレイション ワンステップ側方流非吸収性アッセイ
US20050196875A1 (en) * 1995-08-09 2005-09-08 Blatt Joel M. Dry reagent particle assay and device having multiple test zones and method therefor
JP2007139538A (ja) * 2005-11-17 2007-06-07 Asahi Kasei Corp 標識付き試薬およびその製造方法、およびこれを用いた分析装置
JP2008526747A (ja) * 2004-12-30 2008-07-24 ジェンザイム・コーポレイション 関節内粘性補充のための療法
JP2010508513A (ja) * 2006-11-01 2010-03-18 ベックマン コールター， インコーポレイテッド 親和性アッセイのための結合表面
JP2015507078A (ja) * 2011-11-15 2015-03-05 メタロー テクノロジーズ インターナショナル エスエー 金属／シリカコア／シェルナノ粒子、および作製方法、ならびに該粒子を含む免疫クロマトグラフィー検査デバイス
JP2015052595A (ja) * 2013-08-07 2015-03-19 古河電気工業株式会社 複合標識粒子、これを用いた標的物質の検出方法、コロイド液および標識試薬、ならびに複合標識粒子の製造方法
JP2015194495A (ja) * 2014-03-28 2015-11-05 大日本塗料株式会社 イムノクロマトキット
JP2017524140A (ja) * 2014-08-13 2017-08-24 アバクシス， インコーポレイテッド プラズモン特異的結合パートナーアッセイにおけるシグナル増幅
JP2017524671A (ja) * 2014-06-16 2017-08-31 ユニゲン・インコーポレーテッド 骨障害、軟骨障害又はその両方の管理又は改善用組成物及び方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374561A (en) 1993-10-25 1994-12-20 Miles Inc. Oxidative creatinine assay
US6979576B1 (en) 1997-07-25 2005-12-27 Shu-Ching Cheng Methods of use of one step immunochromatographic device for Streptococcus A antigen
US6001656A (en) 1998-09-28 1999-12-14 Bayer Corporation Method for the detection of creatinine
US20070004658A1 (en) * 2004-06-21 2007-01-04 Nick Vandeghinste Method and means for treatment of osteoarthritis
ATE440609T1 (de) * 2006-05-11 2009-09-15 Sandra Gobbo Binäre hyaluronsäure-gemische und ihre therapeutische verwendung
CN200968955Y (zh) * 2006-07-26 2007-10-31 艾博生物医药(杭州)有限公司 生物液体样本分析装置
US20080138842A1 (en) * 2006-12-11 2008-06-12 Hans Boehringer Indirect lateral flow sandwich assay
CN101363849A (zh) * 2008-09-24 2009-02-11 深圳市菲鹏生物股份有限公司 间接标记纳米颗粒的抗体检测捕获法及其试剂盒
CN102650638B (zh) * 2011-02-25 2015-11-04 广州固康生物科技有限公司 尿中ii型胶原降解产物检测试剂盒及其制备方法
CN102445537A (zh) * 2011-12-20 2012-05-09 广州万孚生物技术有限公司 一种甲型流感病毒抗原和乙型病毒流感抗原的联检试纸及其制备方法
BR112015008036B1 (pt) 2012-10-11 2022-09-13 Zoetis Services Llc População de peptídeos isolados, método para detectar em uma amostra um anticorpo, método para diagnosticar erliquiose monocítica e/ou granulocítica, método para detectar a presença de anticorpos e kit
CN103913568A (zh) * 2013-01-04 2014-07-09 广州万孚生物技术股份有限公司 一种人体自身抗体联检试纸条及其制备方法
CN103954772B (zh) * 2014-04-30 2016-05-11 广东海大畜牧兽医研究院有限公司 一种猪瘟病毒、猪繁殖与呼吸障碍综合征病毒、伪狂犬病毒抗体的三联金标检测试纸条
CN104297482B (zh) * 2014-09-16 2016-08-17 中山生物工程有限公司 EB病毒VCA/NA1-IgA抗体联合检测试剂及其制备方法
CN204719052U (zh) * 2015-05-15 2015-10-21 德康润生物科技（天津）有限公司 联合检测结核分枝杆菌抗体的试剂盒
EP3156801A1 (en) * 2015-10-13 2017-04-19 Ludwig-Maximilians-Universität München Sicam-1 as biomarker for pain and pain intensity
US11340217B2 (en) * 2016-03-09 2022-05-24 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Catalytic particles for increased sensitivity in lateral flow immunoassays
RS63770B1 (sr) * 2016-04-15 2022-12-30 Esm Technologies Llc Postupak za procenu terapeutika za zglobove članaka
CN106370844A (zh) * 2016-08-30 2017-02-01 吕炜锋 人骨代谢标志物检测双胶体金试纸条及应用其的检测装置
CN107688090A (zh) * 2017-07-17 2018-02-13 润和生物医药科技(汕头)有限公司 一种NTx检测试纸、试剂盒及其制备方法
WO2023224993A1 (en) * 2022-05-16 2023-11-23 Xbiologix, Inc. Rapid detection tests and methods of forming the same
US11747336B1 (en) * 2022-06-30 2023-09-05 Xbiologix, Inc. Rapid detection tests with preloaded detection particles

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06504846A (ja) * 1991-01-11 1994-06-02 クイデル　コーポレイション ワンステップ側方流非吸収性アッセイ
US20050196875A1 (en) * 1995-08-09 2005-09-08 Blatt Joel M. Dry reagent particle assay and device having multiple test zones and method therefor
JP2008526747A (ja) * 2004-12-30 2008-07-24 ジェンザイム・コーポレイション 関節内粘性補充のための療法
JP2007139538A (ja) * 2005-11-17 2007-06-07 Asahi Kasei Corp 標識付き試薬およびその製造方法、およびこれを用いた分析装置
JP2010508513A (ja) * 2006-11-01 2010-03-18 ベックマン コールター， インコーポレイテッド 親和性アッセイのための結合表面
JP2015507078A (ja) * 2011-11-15 2015-03-05 メタロー テクノロジーズ インターナショナル エスエー 金属／シリカコア／シェルナノ粒子、および作製方法、ならびに該粒子を含む免疫クロマトグラフィー検査デバイス
JP2015052595A (ja) * 2013-08-07 2015-03-19 古河電気工業株式会社 複合標識粒子、これを用いた標的物質の検出方法、コロイド液および標識試薬、ならびに複合標識粒子の製造方法
JP2015194495A (ja) * 2014-03-28 2015-11-05 大日本塗料株式会社 イムノクロマトキット
JP2017524671A (ja) * 2014-06-16 2017-08-31 ユニゲン・インコーポレーテッド 骨障害、軟骨障害又はその両方の管理又は改善用組成物及び方法
JP2017524140A (ja) * 2014-08-13 2017-08-24 アバクシス， インコーポレイテッド プラズモン特異的結合パートナーアッセイにおけるシグナル増幅

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024075545A (ja) * 2022-11-23 2024-06-04 弗雷米徳生物医薬技術（天津）有限公司 子宮頸癌ｅ７タンパク質検出用抗体抗原検出キット及びその検出方法

Also Published As

Publication number Publication date
EP3775896A1 (en) 2021-02-17
EP3775896C0 (en) 2023-06-07
CN111868528A (zh) 2020-10-30
US12123873B2 (en) 2024-10-22
US20210033605A1 (en) 2021-02-04
EP3775896B1 (en) 2023-06-07
WO2019192978A1 (en) 2019-10-10
ES2953017T3 (es) 2023-11-07
CN111868528B (zh) 2024-10-01

Similar Documents

Publication Publication Date Title
US12123873B2 (en) Lateral flow immunoassay strip device
US8445293B2 (en) Method to increase specificity and/or accuracy of lateral flow immunoassays
US20120015350A1 (en) Lateral flow strip and uses thereof
US20220357338A1 (en) Anti-vla-4 related assays
JP2011514517A (ja) 環状シトルリン化ペプチドに対する抗体のアッセイ方法
JP2003508753A (ja) 中枢神経系の損傷を検出するためのアッセイ
CN106066399A (zh) 检测早期糖尿病肾病的胶体金试纸条的制备方法
US20190041407A1 (en) Devices, systems and methods for quantifying hemoglobin s concentration
JP4509933B2 (ja) アディポネクチン分析用ラテックス試薬及びアディポネクチン分析方法
US8460884B2 (en) Use of hematopoietic growth factor inducible neurokinin-1 (HGFIN) as a biomarker for renal injury or renal disease
US20030059370A1 (en) In vivo diagnostic apparatus and methods thereof
JPS6281567A (ja) 粒子凝集反応を用いる定量方法
JPWO2019192978A5 (https=)
US12298302B2 (en) Systems and methods for rheumatoid arthritis biomarker detection
US20220276264A1 (en) DARPin REAGENTS THAT DISTINGUISH ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE SAMPLES
JP6329127B2 (ja) 細胞フィブロネクチンについての迅速な検査
JP2000111553A (ja) 正常アグリカン測定法とその応用
JP3665698B2 (ja) 慢性関節リウマチ用マーカーとしての使用および慢性関節リウマチ診断用免疫試薬
CN115078230A (zh) 用于取得脊髓性肌萎缩症相关信息的方法、试剂盒及装置
Kao et al. Developing and assessing an immunochromatographic strip for detecting osteoarthritis based on urine cartilage oligomeric matrix proteins
CN121656556A (zh) 检测异种移植器官排斥
WO2013144615A1 (en) Biological reagent
WO2014074729A1 (en) Collagen iv binding assay for the detection of collagen vii
HK1256154B (en) Anti-vla-4 related assays
JPH11118797A (ja) 若年性関節リウマチの検査方法および検査薬

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220323

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220323

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230704

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231017

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240307

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240417

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240802

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20241203

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20241227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250311

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250402

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250509

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20250926